These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 25696892)

  • 1. Thrombotic microangiopathy and indications for therapeutic plasma exchange.
    Adamski J
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):444-9. PubMed ID: 25696892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic and therapeutic guidelines of thrombotic microangiopathies of the Spanish Apheresis Group].
    Contreras E; de la Rubia J; Del Río-Garma J; Díaz-Ricart M; García-Gala JM; Lozano M;
    Med Clin (Barc); 2015 Apr; 144(7):331.e1-331.e13. PubMed ID: 25433791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
    Williams LA; Marques MB;
    Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Thrombotic Microangiopathy: A Review.
    Genest DS; Patriquin CJ; Licht C; John R; Reich HN
    Am J Kidney Dis; 2023 May; 81(5):591-605. PubMed ID: 36509342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center.
    Martin SD; McGinnis E; Smith TW
    Am J Clin Pathol; 2021 Nov; 156(6):1103-1112. PubMed ID: 34160013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients.
    Page EE; Little DJ; Vesely SK; George JN
    Am J Kidney Dis; 2017 Nov; 70(5):686-695. PubMed ID: 28780041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and treatment of microangiopathic hemolytic anemia].
    Morishita E
    Rinsho Ketsueki; 2015 Jul; 56(7):795-806. PubMed ID: 26251142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic Microangiopathy Syndrome in a Basic Underwater Demolition/SEAL Student.
    Croom D; Tracy H
    J Spec Oper Med; 2016; 16(3):16-19. PubMed ID: 27734437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
    Clark WF
    Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic Microangiopathy: A Multidisciplinary Team Approach.
    Gordon CE; Chitalia VC; Sloan JM; Salant DJ; Coleman DL; Quillen K; Ravid K; Francis JM
    Am J Kidney Dis; 2017 Nov; 70(5):715-721. PubMed ID: 28720207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia.
    George JN; Charania RS
    Semin Thromb Hemost; 2013 Mar; 39(2):153-60. PubMed ID: 23390027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HUS and TTP: traversing the disease and the age spectrum.
    Donadelli R; Sinha A; Bagga A; Noris M; Remuzzi G
    Semin Nephrol; 2023 Jul; 43(4):151436. PubMed ID: 37949684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic microangiopathy in children.
    Palma LMP; Vaisbich-Guimarães MH; Sridharan M; Tran CL; Sethi S
    Pediatr Nephrol; 2022 Sep; 37(9):1967-1980. PubMed ID: 35041041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative.
    Bendapudi PK; Li A; Hamdan A; Uhl L; Kaufman R; Stowell C; Dzik W; Makar RS
    Br J Haematol; 2015 Dec; 171(5):836-44. PubMed ID: 26314936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic microangiopathies: from animal models to human disease and cure.
    Caprioli J; Remuzzi G; Noris M
    Contrib Nephrol; 2011; 169():337-350. PubMed ID: 21252531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology and management of thrombotic microangiopathies.
    Ruggenenti P; Remuzzi G
    J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Thrombotic Microangiopathic Hemolytic Anemias with Therapeutic Plasma Exchange: When It Works and When It Does Not.
    Mehmood T; Taylor M; Winters JL
    Hematol Oncol Clin North Am; 2016 Jun; 30(3):679-94. PubMed ID: 27113004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies: Lessons learned from a 14-year retrospective study.
    Tau J; Fernando LP; Munoz MC; Poh C; Krishnan VV; Dwyre DM
    Ther Apher Dial; 2023 Feb; 27(1):136-145. PubMed ID: 35501999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronavirus disease 2019-associated thrombotic microangiopathy treated with plasma exchange and antihypertensive therapy in a patient with HIV: A case report with literature review.
    Masuda E; Fukushima K; Hebisawa Y; Tanaka M; Ohta A; Imamura A
    Medicine (Baltimore); 2023 Oct; 102(41):e35469. PubMed ID: 37832064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.